HOME >> BIOLOGY >> NEWS
Potential new therapeutic target for asthma, allergies and cancer

Virginia Commonwealth University researchers have identified how a bioactive molecule involved with allergy, inflammation and cancer is transported out of mast cells, according to findings published online this week in the Proceedings of the National Academy of Sciences.

Mast cells are specialized cells that react to allergy-causing agents by releasing substances that trigger the body's allergic response, leading to conditions like asthma and hives. Among the molecules released by mast cells that participate in the allergic response is sphingosine-1-phosphate. This molecule is also implicated in cancer.

The work by the VCU investigators opens up a new approach to treating asthma, which affects about 15 million Americans and is increasing in incidence and mortality, especially among African-Americans. It also has implications for other allergic disorders and for cancer in terms of developing drugs that inhibit the transport of SIP out of cells.

Sarah Spiegel, Ph.D., professor and chair, VCU Department of Biochemistry, and colleagues reported how S1P, which also regulates many important physiological functions in cells, is transported out of mast cells. S1P is produced by all cells and secreted by some cells into the circulation where it can bind to specific S1P receptors. Until now, researchers have not known the mechanism by which S1P is transported out of cells.

"Our study shows that mast cells can use a special kind of transporter that has long been known to be used by cancer cells to push anti-cancer drugs out and help them survive the treatment," said Spiegel. "Our study is the first to establish a mechanism by which S1P can be exported out of mast cells and perhaps by cancer cells as well."

In previous research, Spiegel's team found that S1P levels are significantly elevated in fluid collected from the lungs of asthmatic patients after exposure to an allergen. Those findings led Spiegel's team to believe that ma
'"/>

Contact: Sathya Achia-Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
17-Oct-2006


Page: 1 2

Related biology news :

1. Potential genetic testing for substance abuse raises hope, concern
2. Potential for malaria transmission higher than previously thought
3. Potential diagnostic marker indicates effectiveness of anti-angiogenic drugs
4. Potential new treatment strategy for Alzheimers disease and other brain and spinal cord damage
5. Potential vaccine developed for deadly leishmaniasis disease
6. LIAI initiatives battle influenza; Potential bird flu treatment among their findings
7. Potential malaria drug target identified
8. Potentially harmful fluoride levels found in some instant teas
9. Potential new oncogene may be missing link in cancer-causing chain
10. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
11. From clinical cancer research: rethinking therapeutic cancer vaccine trials

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... ... At nearly eleven years old, Seve, a white Golden Retriever, began showing symptoms ... year or so, he was a little “gimpy” and occasionally his back legs would ... University Animal Hospital in Dallas, diagnosed him with severe osteoarthritis in his hips ...
(Date:7/11/2019)... ... July 11, 2019 , ... ... announced a partnership with LiquiTech, a leader in Legionella prevention for the ... will integrate Spartan’s innovative environmental DNA testing platform to provide a new ...
(Date:7/9/2019)... (PRWEB) , ... July 09, 2019 , ... ... accepted Tx Genetic Research into its incubator program. The founder and CEO of ... to improve the lives of those suffering from epithelial connective tissue disorders. , ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent stem ... to eight military Veterans under the R3 Heroes Program. The Veterans included individuals and ... Heroes Program allow anyone to nominate a military Veteran, teacher or first responder to ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from preclinical ... Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical ... change in crystallite size , Over 142% increase in particle size , ...
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology Ltd ... appointment of Biofeedback Tech Ltd as its authorised distributor for the ... of many therapeutic treatments and clinical assessment protocols to treat stress related disorders ...
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility ... Food and Drug Branch for manufacturing. This is an important milestone for ...
Breaking Biology Technology:
Cached News: